Complement activation: A critical mediator of adverse fetal outcomes in placental malaria

Trends in Parasitology

Volumn 27, Issue 7, 2011, Pages 294-299

  Conroy, Andrea L ^a   McDonald, Chloe R ^a   Silver, Karlee L ^a   Liles, W Conrad ^a,b   Kain, Kevin C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD59 ANTIGEN; COMPLEMENT COMPONENT C5A; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ANGIOGENESIS; COMPLEMENT ACTIVATION; DISEASE SIMULATION; FETUS OUTCOME; HUMAN; IMMUNOPATHOGENESIS; INTRAUTERINE GROWTH RETARDATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LOW BIRTH WEIGHT; MALARIA; MATERNAL DISEASE; MOLECULAR PATHOLOGY; MONONUCLEAR CELL; NONHUMAN; PARASITE LOAD; PLACENTA CIRCULATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREGNANCY OUTCOME; REGULATORY MECHANISM; REVIEW; TROPHOBLAST;

COMPLEMENT ACTIVATION; COMPLEMENT C5A; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME;

MURINAE;

EID: 79959363870     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.02.005     Document Type: Review

References (50)

1. Guyatt H.L., Snow R.W. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:569-576.
2. Murphy S.C., Breman J.G. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg. 2001, 64(Suppl. 1):57-67.
3. Dellicour S., et al. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010, 7:e1000221.
4. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996, 272:1502-1504.
5. Fried M., et al. Maternal antibodies block malaria. Nature 1998, 395:851-852.
6. Keen J., et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007, 4:e181.
7. Rogerson S.J., et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis. 2007, 7:105-117.
8. Fried M., et al. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J. Immunol. 1998, 160:2523-2530.
9. Rogerson S.J., et al. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am. J. Trop. Med. Hyg. 2003, 68:115-119.
10. Rogerson S.J., et al. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect. Immun. 2003, 71:267-270.
11. Moormann A.M., et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J. Infect. Dis. 1999, 180:1987-1993.
12. Menendez C., et al. The impact of placental malaria on gestational age and birth weight. J. Infect. Dis. 2000, 181:1740-1745.
13. Girardi G., et al. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 2006, 203:2165-2175.
14. Conroy A., et al. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS ONE 2009, 4:e4953.
15. Ward P.A. The dark side of C5a in sepsis. Nat. Rev. Immunol. 2004, 4:133-142.
16. Huber-Lang M., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12:682-687.
17. Huber-Lang M., et al. Generation of C5a by phagocytic cells. Am. J. Pathol. 2002, 161:1849-1859.
18. Fukuoka Y., et al. Generation of anaphylatoxins by human {beta}-tryptase from C3, C4, and C5. J. Immunol. 2008, 180:6307-6316.
19. Silver K.L., et al. Complement driven innate immune response to malaria: fuelling severe malarial diseases. Cell. Microbiol. 2010, 12:1036-1045.
20. Richani K., et al. Normal pregnancy is characterized by systemic activation of the complement system. J. Matern. Fetal Neonatal Med. 2005, 17:239-245.
21. Tedesco F., et al. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J. Immunol. 1993, 151:1562-1570.
22. Vaisbuch E., et al. Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation. J. Matern. Fetal Neonatal Med. 2009, 22:905-916.
23. Soto E., et al. Anaphylatoxins in preterm and term labor. J. Perinat. Med. 2005, 33:306-313.
24. Richani K., et al. Unexplained intrauterine fetal death is accompanied by activation of complement. J. Perinat. Med. 2005, 33:296-305.
25. Lynch A.M., et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am. J. Obstet. Gynecol. 2008, 198. 385.e1-9.
26. Soto E., et al. Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. J. Matern. Fetal Neonatal Med. 2010, 23:646-657.
27. Haeger M., et al. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 1992, 79:19-26.
28. Soto E., et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J. Matern. Fetal Neonatal Med. 2005, 17:247-252.
29. Kelly R., et al. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Br. J. Haematol. 2010, 149:446-450.
30. Danilov A.V., et al. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab. Leuk. Res. 2010, 34:566-571.
31. Hviid L., et al. Of mice and women: rodent models of placental malaria. Trends Parasitol. 2010, 26:412-419.
32. Georgiades P., et al. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 2002, 23:3-19.
33. Holers V.M., et al. Complement C3 activation is required for antiphospholipid antibody-induced Fetal Loss. J. Exp. Med. 2002, 195:211-220.
34. Girardi G., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 2003, 112:1644-1654.
35. Redecha P., et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury. Blood 2007, 110:2423-2431.
36. Girardi G. Guilty as charged: all available evidence implicates complement's role in fetal demise. Am. J. Reprod. Immunol. 2008, 59:183-192.
37. Lynch A.M., et al. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG 2010, 117:456-462.
38. Muehlenbachs A., et al. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J. Immunol. 2007, 179:557-565.
39. Yamada M., et al. Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. Am. J. Trop. Med. Hyg. 1989, 41:161-168.
40. Muehlenbachs A., et al. Hypertension and maternal-fetal conflict during placental malaria. PLoS Med. 2006, 3:e446.
41. Muehlenbachs A., et al. Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14488-14491.
42. Walter P.R., et al. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am. J. Pathol. 1982, 109:330-342.
43. Leke R., et al. Plasmodium falciparum infection in pregnant Cameroonian women: an assessment of changes in the placenta of low birth weight infants. J. Cameroon Acad. Sci. 2002, 2(Suppl.):203-212.
44. Dorman E.K., et al. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet. Gynecol. 2002, 19:165-170.
45. Arbeille P., et al. Consequences of reduced umbilical and increased foetal cerebral flow during malaria crisis on foetal behaviour. Parasitology 2003, 126(Pt 6):513-519.
46. Silver K.L., et al. Dysregulation of angiopoietins is associated with placental malaria and low birth weight. PLoS ONE 2010, 5:e9481.
47. Yancopoulos G.D., et al. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
48. McGready R., et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am. J. Trop. Med. Hyg. 2004, 70:398-407.
49. Nosten F., et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999, 354:546-549.
50. Poespoprodjo J.R., et al. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin. Infect. Dis. 2008, 46:1374-1381.